Compare Bristol-Myers Squibb Co (BMY) vs Amplify Cybersecurity ETF (HACK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Amplify Cybersecurity ETF — how do they compare? Bristol-Myers Squibb Co trades at $57.13 (market cap $121.18B), while Amplify Cybersecurity ETF trades at $115.86. The key difference: Bristol-Myers Squibb Co pays a 4.25% dividend while Amplify Cybersecurity ETF pays none, and Amplify Cybersecurity ETF is trading nearer its 52-week high, Bristol-Myers Squibb Co nearer its low. Which is the better fit depends on your goals.
| BMY | HACK | |
|---|---|---|
Market Cap | $121.18B | — |
Sector | Health | Sector/Thematic |
52-Week High | $62.37 | $114.29 |
52-Week Low | $42.60 | $70.69 |
Enterprise Value | $157.12B | — |
Dividend Yield | 4.25% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Amplify Cybersecurity ETF
HACK provides diversified exposure to the global cybersecurity industry. It invests across the full value chain, including hardware, software, and consulting services, with key holdings in firms like Broadcom, Cisco, and Palo Alto Networks.
Read more on HACK →
